By Armen Hareyan on December 28, 2007 - 12:39pm 
for eMaxHealth
for eMaxHealthVinflunine shows encouragin sings for treatment in Malignant Pleural Mesothelioma.
Malignant pleural mesothelioma (MPM) is a disease of increasing incidence for which treatment options are limited. This study reports the clinical efficacy data for vinflunine, a novel microtubule inhibitor, in MPM.
Patients and Methods: Patients with a histologically confirmed diagnosis of
Source:
Journal of Clinical Oncology eMaxHealth welcomes yourcomments and feedback on this story without registration, but keep the comments meaningful please. Links are not accepted.
